Outcomes4Me Secures $21M to Enhance AI-Driven Cancer Care

Outcomes4Me has secured $21 million in funding to advance its AI-driven platform for cancer care, announced in a press release. The funding round includes new investor Salica Investments and existing backers such as Labcorp Venture Fund and Sierra Ventures, bringing the company's total capital raised to $38 million.

The Boston-based company aims to use the funds to enhance its platform, which integrates clinical guidelines, genomic insights, and clinical trial matching into a user-friendly interface for cancer patients. Outcomes4Me plans to expand its market reach across various cancer types and geographies, leveraging its proprietary datasets to offer more precise treatment recommendations.

With over 280,000 cancer patients already using its platform, Outcomes4Me is focused on scaling its operations and strengthening collaborations with top-tier health systems and life sciences companies globally. The company is also committed to driving revenue growth through new partnerships and innovative business models.